Mozambique - External resources for health (% of total expenditure on health)

External resources for health (% of total expenditure on health) in Mozambique was reported at 48.69 % in 2014, according to the World Bank collection of development indicators, compiled from officially recognized sources.



mozambique external resources for health percent of total expenditure on health wb data
Please Paste this Code in your Website
width
height
 Preview




We will not not share your email with third parties and you can unsubscribe at any time.
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Learn More Register Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Learn More Interested? Click here to contact us




External resources for health are funds or services in kind that are provided by entities not part of the country in question. The resources may come from international organizations, other countries through bilateral arrangements, or foreign nongovernmental organizations. These resources are part of total health expenditure.


Mozambique | Health

Ratio of school attendance of orphans to school attendance of non-orphans ages 10-14
0.91
Proportion of women subjected to physical and/or sexual violence in the last 12 months ( % of women age 15-49)
27.7 %
Women who believe a husband is justified in beating his wife when she argues with him
12.3 %
Women who believe a husband is justified in beating his wife when she burns the food
6.4 %
Women who believe a husband is justified in beating his wife when she goes out without telling him
8.6 %
Women who believe a husband is justified in beating his wife when she neglects the children
7.5 %
Women who believe a husband is justified in beating his wife (any of five reasons)
21 %
Women who believe a husband is justified in beating his wife when she refuses sex with him
5.8 %
Problems in accessing health care (not wanting to go alone) (% of women): Q1 (lowest)
29.7 %
Problems in accessing health care (not wanting to go alone) (% of women): Q2
28.6 %
Problems in accessing health care (not wanting to go alone) (% of women): Q3
22.3 %
Problems in accessing health care (not wanting to go alone) (% of women): Q4
12.9 %
Problems in accessing health care (not wanting to go alone) (% of women): Q5 (highest)
6.9 %
Problems in accessing health care (distance to health facility) (% of women): Q1 (lowest)
80.3 %
Problems in accessing health care (distance to health facility) (% of women): Q2
75.4 %
Problems in accessing health care (distance to health facility) (% of women): Q3
61 %
Problems in accessing health care (distance to health facility) (% of women): Q4
40.9 %
Problems in accessing health care (distance to health facility) (% of women): Q5 (highest)
15.5 %
Problems in accessing health care (getting money for treatment) (% of women): Q1 (lowest)
65.6 %
Problems in accessing health care (getting money for treatment) (% of women): Q2
53.6 %
Problems in accessing health care (getting money for treatment) (% of women): Q3
42.6 %
Problems in accessing health care (getting money for treatment) (% of women): Q4
28.7 %
Problems in accessing health care (getting money for treatment) (% of women): Q5 (highest)
15.3 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q1 (lowest)
12.7 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q2
10.4 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q3
9.2 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q4
8 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q5 (highest)
7 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q1 (lowest)
16.7 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q2
16.7 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q3
11.8 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q4
6.5 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q5 (highest)
4.4 %
Problems in accessing health care (any of the specified problems) (% of women): Q1 (lowest)
88.8 %
Problems in accessing health care (any of the specified problems) (% of women): Q2
82.9 %
Problems in accessing health care (any of the specified problems) (% of women): Q3
69 %
Problems in accessing health care (any of the specified problems) (% of women): Q4
52 %
Problems in accessing health care (any of the specified problems) (% of women): Q5 (highest)
25.9 %
Problems in accessing health care (having to take transport) (% of women): Q1 (lowest)
76.5 %
Problems in accessing health care (having to take transport) (% of women): Q2
66.6 %
Problems in accessing health care (having to take transport) (% of women): Q3
55.6 %
Problems in accessing health care (having to take transport) (% of women): Q4
34.8 %
Problems in accessing health care (having to take transport) (% of women): Q5 (highest)
18 %
Problems in accessing health care (knowing where to go for treatment) (% of women): Q1 (lowest)
22 %
Problems in accessing health care (knowing where to go for treatment) (% of women): Q2
15.3 %
Problems in accessing health care (knowing where to go for treatment) (% of women): Q3
11.5 %
Problems in accessing health care (knowing where to go for treatment) (% of women): Q4
6.6 %
Problems in accessing health care (knowing where to go for treatment) (% of women): Q5 (highest)
5.7 %
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
2
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
44.2 %
Prevalence of anemia among children (% of children under 5)
66.5 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
43.7 %
Condom use; population ages 15-24; female (% of females ages 15-24)
15.6 %
Condom use; population ages 15-24; male (% of males ages 15-24)
33.3 %
Condom use with non regular partner, % adults(15-49), female
34.2 %
Condom use with non regular partner, % adults(15-49), male
40.9 %
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
59.3 %
Number of infant deaths
60138
Cause of death, by injury (% of total)
9.1 %
Number of under-five deaths
82387
Cause of death, by non-communicable diseases (% of total)
31.6 %
Number of neonatal deaths
28799
Adults (ages 15+) living with HIV
1400000 Persons
AIDS estimated deaths (UNAIDS estimates)
39000
Female adults with HIV (% of population ages 15+ with HIV)
59.89 %
Prevalence of HIV, total (% of population ages 15-49)
10.5 %
Mortality rate, female child (per 1,000 female children age one)
63.7
Mortality rate, under-5 (per 1,000)
78.5
Mortality rate, under-5, female (per 1,000 live births)
73.9
Mortality rate, under-5, male (per 1,000 live births)
82.9
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
129
Under-5 mortality rate (per 1,000 live births): Q2
105
Under-5 mortality rate (per 1,000 live births): Q3
114
Under-5 mortality rate (per 1,000 live births): Q4
95
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
91
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
23 %
Mortality rate; neonatal (per 1;000 live births)
27.1
Acceptability of media messages on family planning (% of women): Q1 (lowest)
44.2 %
Acceptability of media messages on family planning (% of women): Q2
49.5 %
Acceptability of media messages on family planning (% of women): Q3
44.6 %
Acceptability of media messages on family planning (% of women): Q4
51.5 %
Acceptability of media messages on family planning (% of women): Q5 (highest)
69.9 %
Attitudes of couples toward family planning (husband approves) (% of married non-sterilized women): Q1 (lowest)
44.3 %
Attitudes of couples toward family planning (husband approves) (% of married non-sterilized women): Q2
43.9 %
Attitudes of couples toward family planning (husband approves) (% of married non-sterilized women): Q3
53 %
Attitudes of couples toward family planning (husband approves) (% of married non-sterilized women): Q4
50.8 %
Attitudes of couples toward family planning (husband approves) (% of married non-sterilized women): Q5 (highest)
68.8 %
Attitudes of couples toward family planning (respondent approves) (% of married non-sterilized women): Q1 (lowest)
68.6 %
Attitudes of couples toward family planning (respondent approves) (% of married non-sterilized women): Q2
73.8 %
Attitudes of couples toward family planning (respondent approves) (% of married non-sterilized women): Q3
75.7 %
Attitudes of couples toward family planning (respondent approves) (% of married non-sterilized women): Q4
80 %
Attitudes of couples toward family planning (respondent approves) (% of married non-sterilized women): Q5 (highest)
89.9 %
Median age at first birth (women ages 25-49): Q1 (lowest)
19.9
Median age at first birth (women ages 25-49): Q2
19.5
Median age at first birth (women ages 25-49): Q3
18.8
Median age at first birth (women ages 25-49): Q4
19.1
Median age at first birth (women ages 25-49): Q5 (highest)
19.7
Median age at first marriage (women ages 25-49): Q1 (lowest)
18.9
Median age at first marriage (women ages 25-49): Q2
18.4
Median age at first marriage (women ages 25-49): Q3
18.1
Median age at first marriage (women ages 25-49): Q4
18.4
Median age at first marriage (women ages 25-49): Q5 (highest)
20.3
Median age at first sexual intercourse (women ages 25-49): Q1 (lowest)
15.7
Median age at first sexual intercourse (women ages 25-49): Q2
15.7
Median age at first sexual intercourse (women ages 25-49): Q3
15.8
Median age at first sexual intercourse (women ages 25-49): Q4
16.2
Median age at first sexual intercourse (women ages 25-49): Q5 (highest)
17
Heard family planning on radio and television (% of women): Q1 (lowest)
0.6 %
Heard family planning on radio and television (% of women): Q2
1.8 %
Heard family planning on radio and television (% of women): Q3
4 %
Heard family planning on radio and television (% of women): Q4
17.3 %
Heard family planning on radio and television (% of women): Q5 (highest)
40.6 %
Mean ideal number of children (per woman): Q1 (lowest)
5.5
Mean ideal number of children (per woman): Q2
5.6
Mean ideal number of children (per woman): Q3
5.3
Mean ideal number of children (per woman): Q4
4.6
Mean ideal number of children (per woman): Q5 (highest)
3.5
Knowledge of contraception (any method) (% of married women): Q1 (lowest)
95.8 %
Knowledge of contraception (any method) (% of married women): Q2
94.4 %
Knowledge of contraception (any method) (% of married women): Q3
94.9 %
Knowledge of contraception (any method) (% of married women): Q4
97.5 %
Knowledge of contraception (any method) (% of married women): Q5 (highest)
99.6 %
Knowledge of contraception (modern method) (% of married women): Q1 (lowest)
95.7 %
Knowledge of contraception (modern method) (% of married women): Q2
94.3 %
Knowledge of contraception (modern method) (% of married women): Q3
94.8 %
Knowledge of contraception (modern method) (% of married women): Q4
97.5 %
Knowledge of contraception (modern method) (% of married women): Q5 (highest)
99.6 %
Desire to stop (limit) childbearing (% of married women): Q1 (lowest)
23 %
Desire to stop (limit) childbearing (% of married women): Q2
22 %
Desire to stop (limit) childbearing (% of married women): Q3
26.6 %
Desire to stop (limit) childbearing (% of married women): Q4
30.8 %
Desire to stop (limit) childbearing (% of married women): Q5 (highest)
40.8 %
Median birth interval (months): Q1 (lowest)
33
Median birth interval (months): Q2
33.7
Median birth interval (months): Q3
34.7
Median birth interval (months): Q4
35.8
Median birth interval (months): Q5 (highest)
41.7
Fertility planning status (wanted later) (% of births): Q1 (lowest)
5.2 %
Fertility planning status (wanted later) (% of births): Q2
7.4 %
Fertility planning status (wanted later) (% of births): Q3
9.8 %
Fertility planning status (wanted later) (% of births): Q4
15.5 %
Fertility planning status (wanted later) (% of births): Q5 (highest)
24.9 %
Family planning messages in print (% of women): Q1 (lowest)
0.4 %
Family planning messages in print (% of women): Q2
1.2 %
Family planning messages in print (% of women): Q3
2.5 %
Family planning messages in print (% of women): Q4
7.6 %
Family planning messages in print (% of women): Q5 (highest)
27.2 %
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
31.9 %
Fertility planning status (wanted no more) (% of births): Q1 (lowest)
1.7 %
Fertility planning status (wanted no more) (% of births): Q2
1.2 %
Fertility planning status (wanted no more) (% of births): Q3
2.3 %
Fertility planning status (wanted no more) (% of births): Q4
4.7 %
Fertility planning status (wanted no more) (% of births): Q5 (highest)
7.7 %
Fertility planning status (wanted then) (% of births): Q1 (lowest)
93.1 %
Fertility planning status (wanted then) (% of births): Q2
91.5 %
Fertility planning status (wanted then) (% of births): Q3
87.9 %
Fertility planning status (wanted then) (% of births): Q4
79.8 %
Fertility planning status (wanted then) (% of births): Q5 (highest)
67.5 %
Access to an improved water source, rural (% of rural population): Q1 (lowest)
28 %
Access to an improved water source, rural (% of rural population): Q2
27 %
Access to an improved water source, rural (% of rural population): Q3
33 %
Access to an improved water source, rural (% of rural population): Q4
40 %
Access to an improved water source , rural (% of rural population): Q5 (highest)
60 %
Access to an improved water source, urban (% of urban population): Q1 (lowest)
44 %
Access to an improved water source, urban (% of urban population): Q2
70 %
Access to an improved water source, urban (% of urban population): Q3
91 %
Access to an improved water source, urban (% of urban population): Q4
95 %
Access to an improved water source, urban (% of urban population): Q5 (highest)
98 %
Children (0-14) living with HIV
110000 Persons
Prevalence of HIV, female (% ages 15-24)
4 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
30.2
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)
51.8
Prevalence of HIV, male (% ages 15-24)
2.3 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
53 %
AIDS deaths in adults and children (high estimate)
92000
AIDS deaths in adults and children (low estimate)
57000
AIDS deaths in adults and children
74000
Adults (ages 15+) newly infected with HIV
75000
Children (ages 0-14) newly infected with HIV
6600
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
81000
Incidence of HIV (% of uninfected population ages 15-49)
0.71 %
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
30.9 %
% of males ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
50.7 %
Children orphaned by HIV/AIDS
590000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
95 %
Adults (ages 15+) and children (0-14 years) living with HIV
1500000 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
53.8 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
57.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
66.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
73.5 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
75.5 %
Immunization, Hib3 (% of children ages 12-23 months)
80 %
Immunization, BCG (% of one-year-old children)
95 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
86.3 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
88.3 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
92.6 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
96 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
94.9 %
Immunization, DPT (% of children ages 12-23 months)
80 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
64.9 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
70.2 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
79.2 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
85.3 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
87.1 %
Immunization, measles (% of children ages 12-23 months)
85 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
74.8 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
74.9 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
79.3 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
91 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
92.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
9.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
5.1 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
3.1 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
2.3 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
1.6 %
Immunization, Pol3 (% of one-year-old children)
80 %
Hospital beds
0.7
Nurses and midwives
0.412
Physicians
0.04
Specialist surgical workforce (per 100,000 population)
0.56
Deaths among children under five years of age due to malaria
18.9 %
Reported malaria deaths (total)
3086
Notified cases of malaria (per 100;000 people)
32555
Incidence of malaria (per 1,000 population at risk)
298
Mosquito net use by children (any mosquito net) (% of children under 5): Q1 (lowest)
34 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q2
37.4 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q3
38.6 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q4
38.7 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q5 (highest)
49.2 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q1 (lowest)
48 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q2
53.5 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q3
56.3 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q4
60.8 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q5 (highest)
68.7 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q1 (lowest)
31.4 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q2
31.5 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q3
38 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q4
40 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q5 (highest)
48 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q2
35.7 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q3
35.9 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q4
36.1 %
Use of insecticide-treated bed nets (% of under-5 population)
35.7 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q1 (lowest)
45 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q2
50.1 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q3
52 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q4
55.4 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q5 (highest)
55.9 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q1 (lowest)
30.7 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q2
30.8 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q3
35 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q4
38.2 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q5 (highest)
41.1 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q1 (lowest)
32.8 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q2
35 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q3
38.7 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q4
43.4 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q5 (highest)
54.6 %
Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women)
18.6 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q1 (lowest)
17.6 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q2
15.6 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q3
18.4 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4
22.8 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q5 (highest)
26.1 %
Treatment of fever (% of children under 5 with fever): Q1 (lowest)
36.1 %
Treatment of fever (% of children under 5 with fever): Q2
23.7 %
Treatment of fever (% of children under 5 with fever): Q3
41.2 %
Treatment of fever (% of children under 5 with fever): Q4
26.9 %
Treatment of fever (% of children under 5 with fever): Q5 (highest)
17.1 %
Children with fever receiving antimalarial drugs (% of children under age 5 with fever)
29.9 %
Number of maternal mortality deaths
5300
Lifetime risk of maternal death (1 in: rate varies by country)
40
Lifetime risk of maternal death
2.53 %
Prevalence of anemia among pregnant women
48.2 %
Prevalence of syphilis (% of women attending antenatal care)
5.8 %
Smoking prevalence, females (% of adults)
5.9 %
Smoking (% of women): Q1 (lowest)
4.9 %
Smoking (% of women): Q2
3.8 %
Smoking (% of women): Q3
3.8 %
Smoking (% of women): Q4
1.6 %
Smoking (% of women): Q5 (highest)
0.9 %
Smoking prevalence, males (% of adults)
31.4 %
Risk of catastrophic expenditure for surgical care (% of people at risk)
27.3 %
Risk of impoverishing expenditure for surgical care (% of people at risk)
80.5 %
Improved sanitation facilities (% of population with access)
20.5 %
Access to improved sanitation facilities, rural (% of rural population): Q1 (lowest)
8 %
Access to improved sanitation facilities, rural (% of rural population): Q2
9 %
Access to improved sanitation facilities, rural (% of rural population): Q3
14 %
Access to improved sanitation facilities, rural (% of rural population): Q4
16 %
Access to improved sanitation facilities, rural (% of rural population): Q5 (highest)
27 %
Improved sanitation facilities, urban (% of urban population with access)
42.4 %
Access to improved sanitation facilities, urban (% of urban population): Q1 (lowest)
17 %
Access to improved sanitation facilities, urban (% of urban population): Q2
20 %
Access to improved sanitation facilities, urban (% of urban population): Q3
35 %
Access to improved sanitation facilities, urban (% of urban population): Q4
58 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q1 (lowest)
68.4 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q2
74.6 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q3
81.7 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q4
90.1 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q5 (highest)
93 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
50.6 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
83.5 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
88.1 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
91.2 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
95.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
97.3 %
Pregnant women receiving prenatal care
90.6 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
0.1 %
Antenatal care (doctor) (% of women with a birth): Q2
0.4 %
Antenatal care (doctor) (% of women with a birth): Q3
0.5 %
Antenatal care (doctor) (% of women with a birth): Q4
0.7 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
7.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
44.1 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
39.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
49.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
51.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
66.8 %
ARI treatment (% of children under 5 taken to a health provider)
50.2 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
1.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
1.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
1.2 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
1.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
2.1 %
Breastfeeding (% of children under 6 months): Q1 (lowest)
98 %
Breastfeeding (% of children under 6 months): Q2
96.6 %
Breastfeeding (% of children under 6 months): Q3
95.2 %
Breastfeeding (% of children under 6 months): Q4
97.4 %
Breastfeeding (% of children under 6 months): Q5 (highest)
95 %
Exclusive breastfeeding (% of children under 6 months)
41 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
34.2 %
Assistance during delivery (any skilled personnel) (% of births): Q2
39.8 %
Assistance during delivery (any skilled personnel) (% of births): Q3
53.3 %
Assistance during delivery (any skilled personnel) (% of births): Q4
75.5 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
90.7 %
Births attended by skilled health staff (% of total)
54.3 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
31.8 %
Place of delivery (births at health facility) (% of births): Q2
39.1 %
Place of delivery (births at health facility) (% of births): Q3
51.1 %
Place of delivery (births at health facility) (% of births): Q4
74.5 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
91.8 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
0.4 %
Assistance during delivery (doctor) (% of births): Q2
0.5 %
Assistance during delivery (doctor) (% of births): Q3
0.9 %
Assistance during delivery (doctor) (% of births): Q4
2.2 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
12.9 %
Low-birthweight babies (% of births)
16.9 %
Diabetes prevalence (% of population ages 20 to 79)
2.6 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
11.9 %
Prevalence of diarrhea (% of children under 5): Q2
10.1 %
Prevalence of diarrhea (% of children under 5): Q3
11.7 %
Prevalence of diarrhea (% of children under 5): Q4
11 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
10.9 %
Prevalence of children with fever (% of children under 5): Q1 (lowest)
14.3 %
Prevalence of children with fever (% of children under 5): Q2
14.6 %
Prevalence of children with fever (% of children under 5): Q3
13.2 %
Prevalence of children with fever (% of children under 5): Q4
12.6 %
Prevalence of children with fever (% of children under 5): Q5 (highest)
12 %
Infant and young child feeding practices, all 3 IYCF (% children ages 6-23 months)
11 %
Malnourished women (BMI is less than 18.5) (% of women): Q1 (lowest)
11 %
Malnourished women (BMI is less than 18.5) (% of women): Q2
9.4 %
Malnourished women (BMI is less than 18.5) (% of women): Q3
5.1 %
Malnourished women (BMI is less than 18.5) (% of women): Q4
5 %
Malnourished women (BMI is less than 18.5) (% of women): Q5 (highest)
3.5 %
Prevalence of underweight, weight for age, female (% of children under 5)
13.6 %
Prevalence of underweight, weight for age, male (% of children under 5)
17.5 %
Malnourished children (underweight, -2SD) (% of children under 5): Q1 (lowest)
23 %
Malnourished children (underweight, -2SD) (% of children under 5): Q2
17.2 %
Malnourished children (underweight, -2SD) (% of children under 5): Q3
15.2 %
Malnourished children (underweight, -2SD) (% of children under 5): Q4
9.7 %
Malnourished children (underweight, -2SD) (% of children under 5): Q5 (highest)
6.4 %
Malnutrition prevalence, weight for age (% of children under 5)
15.6 %
Malaria cases reported
7718782
Malnourished children (underweight, -3SD) (% of children under 5): Q1 (lowest)
7.5 %
Malnourished children (underweight, -3SD) (% of children under 5): Q2
4.4 %
Malnourished children (underweight, -3SD) (% of children under 5): Q3
4.1 %
Malnourished children (underweight, -3SD) (% of children under 5): Q4
1.7 %
Malnourished children (underweight, -3SD) (% of children under 5): Q5 (highest)
1.6 %
Maternal mortality ratio (modeled estimate, per 100,000 live births)
489
Maternal mortality ratio (national estimate; per 100;000 live births)
443
People practicing open defecation, rural (% of rural population): Q1 (lowest)
69 %
People practicing open defecation, rural (% of rural population): Q2
62 %
People practicing open defecation, rural (% of rural population): Q3
51 %
People practicing open defecation, rural (% of rural population): Q4
45 %
People practicing open defecation, rural (% of rural population): Q5 (highest)
20 %
People practicing open defecation, rural (% of rural population)
52 %
People practicing open defecation, urban (% of urban population): Q1 (lowest)
45 %
People practicing open defecation, urban (% of urban population): Q2
27 %
People practicing open defecation, urban (% of urban population): Q3
6 %
People practicing open defecation, urban (% of urban population): Q4
0 %
People practicing open defecation, urban (% of urban population): Q5 (highest)
0 %
People practicing open defecation, urban (% of urban population)
13.1 %
People practicing open defecation (% of population)
39.5 %
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
55.7 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q1 (lowest)
51.4 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q2
58 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q3
67.4 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q4
68.3 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q5 (highest)
79 %
Knowledge of diarrhea care (% of mothers): Q1 (lowest)
87.2 %
Knowledge of diarrhea care (% of mothers): Q2
89.5 %
Knowledge of diarrhea care (% of mothers): Q3
90.6 %
Knowledge of diarrhea care (% of mothers): Q4
93.7 %
Knowledge of diarrhea care (% of mothers): Q5 (highest)
94.7 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q1 (lowest)
48.9 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q2
57.8 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q3
67.4 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q4
66.6 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q5 (highest)
72.6 %
Diarrhea treatment (% of children under 5 who received ORS packet)
55 %
Prevalence of overweight, female (% of female adults)
27.9 %
Prevalence of overweight, male (% of male adults)
12 %
Prevalence of overweight, weight for height, female (% of children under 5)
7.7 %
Prevalence of overweight, weight for height, male (% of children under 5)
8.1 %
Prevalence of overweight (% of children under 5)
7.9 %
Malnourished children (stunting, -3SD) (% of children under 5): Q1 (lowest)
25.7 %
Malnourished children (stunting, -3SD) (% of children under 5): Q2
24.5 %
Malnourished children (stunting, -3SD) (% of children under 5): Q3
21.8 %
Malnourished children (stunting, -3SD) (% of children under 5): Q4
14.9 %
Malnourished children (stunting, -3SD) (% of children under 5): Q5 (highest)
7.4 %
Prevalence of stunting, height for age, female (% of children under 5)
41 %
Prevalence of stunting, height for age, male (% of children under 5)
45.3 %
Malnourished children (stunting, -2SD) (% of children under 5): Q1 (lowest)
51.1 %
Malnourished children (stunting, -2SD) (% of children under 5): Q2
48 %
Malnourished children (stunting, -2SD) (% of children under 5): Q3
46.4 %
Malnourished children (stunting, -2SD) (% of children under 5): Q4
37.4 %
Malnourished children (stunting, -2SD) (% of children under 5): Q5 (highest)
24.1 %
Malnutrition prevalence, height for age (% of children under 5)
43.1 %
Suicide mortality rate (per 100,000 population)
8.4
Mortality caused by road traffic injury (per 100,000 people)
33.1
Prevalence of wasting, weight for height, female (% of children under 5)
5.5 %
Prevalence of wasting, weight for height, male (% of children under 5)
6.7 %
Malnourished children (wasting, -2SD) (% of children under 5): Q1 (lowest)
9.6 %
Malnourished children (wasting, -2SD) (% of children under 5): Q2
6.1 %
Malnourished children (wasting, -2SD) (% of children under 5): Q3
5.3 %
Malnourished children (wasting, -2SD) (% of children under 5): Q4
4 %
Malnourished children (wasting, -2SD) (% of children under 5): Q5 (highest)
3.2 %
Prevalence of wasting (% of children under 5)
6.1 %
Malnourished children (wasting, -3SD) (% of children under 5): Q1 (lowest)
3.7 %
Malnourished children (wasting, -3SD) (% of children under 5): Q2
2.1 %
Malnourished children (wasting, -3SD) (% of children under 5): Q3
2.1 %
Malnourished children (wasting, -3SD) (% of children under 5): Q4
1.2 %
Malnourished children (wasting, -3SD) (% of children under 5): Q5 (highest)
1.2 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
1.9 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
2.8 %
Prevalence of severe wasting, weight for height (% of children under 5)
2.3 %
Tuberculosis treatment success rate (% of registered cases)
89 %
Tuberculosis case detection rate (all forms)
38
Incidence of tuberculosis (per 100,000 people)
551
Tuberculosis death rate (per 100,000 people)
74
Deaths due to tuberculosis among HIV-negative people, high uncertainty bound (per 100,000 population)
91
Deaths due to tuberculosis among HIV-negative people, low uncertainty bound (per 100,000 population)
17
Tetanus toxoid vaccination (% of live births): Q1 (lowest)
51.6 %
Tetanus toxoid vaccination (% of live births): Q2
54.5 %
Tetanus toxoid vaccination (% of live births): Q3
52.9 %
Tetanus toxoid vaccination (% of live births): Q4
57 %
Tetanus toxoid vaccination (% of live births): Q5 (highest)
61.4 %
Newborns protected against tetanus
83 %
External resources for health (% of total expenditure on health)
48.69 %
Out-of-pocket health expenditure (% of total expenditure on health)
9.48 %
Out-of-pocket health expenditure (% of private expenditure on health)
21.75 %
Health expenditure per capita
42 USD
Health expenditure per capita, PPP (constant 2005 international $)
79.32
Health expenditure, private (% of GDP)
3.04 %
Health expenditure, public (% of total health expenditure)
56.44 %
Health expenditure, public (% of government expenditure)
8.81 %
Health expenditure, public (% of GDP)
3.94 %
Health expenditure, total (% of GDP)
6.98 %
Refugee population by country or territory of asylum
5622
Refugee population by country or territory of origin
57
Number of people who are undernourished
6900000
Prevalence of undernourishment (% of population)
25.3 %
Depth of the food deficit (kilocalories per person per day)
181
Depth of hunger (kilocalories per person per day)
330
Consumption of iodized salt (% of households)
44.8 %
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
58.6 %
Vitamin A supplements for postpartum women (% of women with a birth): Q2
63.8 %
Vitamin A supplements for postpartum women (% of women with a birth): Q3
67.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q4
75.3 %
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
74.5 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
65.4 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
66.3 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
75.5 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
81.7 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
89.9 %
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
99 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
137
Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)
100 %
Mortality rate, adult, female (per 1,000 female adults)
384
Mortality rate, adult, male (per 1,000 male adults)
421
Birth rate, crude
38.81
Death rate, crude
11.24
Mean number of children ever born to women aged 40-49: Q1 (lowest)
6
Mean number of children ever born to women aged 40-49: Q2
6
Mean number of children ever born to women aged 40-49: Q3
5.8
Mean number of children ever born to women aged 40-49: Q4
5.4
Mean number of children ever born to women aged 40-49: Q5 (highest)
4.3
Current use of contraception (modern method) (% of married women): Q1 (lowest)
2.9 %
Current use of contraception (modern method) (% of married women): Q2
5.4 %
Current use of contraception (modern method) (% of married women): Q3
6.9 %
Current use of contraception (modern method) (% of married women): Q4
13.8 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
29.5 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
11.3 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
2.9 %
Current use of contraception (any method) (% of married women): Q2
5.5 %
Current use of contraception (any method) (% of married women): Q3
7.4 %
Current use of contraception (any method) (% of married women): Q4
14 %
Current use of contraception (any method) (% of married women): Q5 (highest)
30.3 %
Contraceptive prevalence (% of women ages 15-49)
11.6 %
Mortality rate, infant, female (per 1,000 live births)
52.7
Mortality rate, infant (per 1,000 live births)
56.7
Mortality rate, infant, male (per 1,000 live births)
60.5
Infant mortality rate (per 1,000 live births): Q1 (lowest)
83
Infant mortality rate (per 1,000 live births): Q2
74
Infant mortality rate (per 1,000 live births): Q3
69
Infant mortality rate (per 1,000 live births): Q4
61
Infant mortality rate (per 1,000 live births): Q5 (highest)
64
Life expectancy at birth, female (years)
56.81 years
Life expectancy at birth, total (years)
55.37 years
Life expectancy at birth, male (years)
54 years
Fertility rate, total (births per woman)
5.3
Total fertility rate (TFR) (births per woman): Q1 (lowest)
7.2
Total fertility rate (TFR) (births per woman): Q2
7.2
Total fertility rate (TFR) (births per woman): Q3
6.3
Total fertility rate (TFR) (births per woman): Q4
5.6
Total fertility rate (TFR) (births per woman): Q5 (highest)
3.7
Survival to age 65, female (% of cohort)
50.36 %
Survival to age 65, male (% of cohort)
44.92 %
Wanted fertility rate (births per woman)
5.2
Total wanted fertility rate (births per woman): Q1 (lowest)
6.4
Total wanted fertility rate (births per woman): Q2
6.5
Total wanted fertility rate (births per woman): Q3
5.5
Total wanted fertility rate (births per woman): Q4
4.8
Total wanted fertility rate (births per woman): Q5 (highest)
3.1
Female headed households (% of households with a female head)
35.6 %
Women who were first married by age 18 (% of women ages 20-24)
48.2 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q1 (lowest)
44.6 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q2
40.8 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q3
44.5 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q4
41.1 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q5 (highest)
22.7 %
Teenage mothers (% of women ages 15-19 who have had children or are currently pregnant)
37.5 %
Female population 00-04
2440000 Persons
Population ages 0-4, female (% of female population)
16.7 %
Male population 00-04
2477000 Persons
Population ages 0-4, male (% of male population)
17.75 %
Female population 05-09
2144000 Persons
Population ages 5-9, female (% of female population)
14.63 %
Male population 05-09
2162000 Persons
Population ages 5-9, male (% of male population)
15.44 %
Female population 10-14
1876000 Persons
Population ages 10-14, female (% of female population)
12.75 %
Male population 10-14
1882000 Persons
Population ages 10-14, male (% of male population)
13.39 %
Female population 15-19
1593000 Persons
Population ages 15-19, female (% of female population)
10.76 %
Male population 15-19
1587000 Persons
Population ages 15-19, male (% of male population)
11.23 %
Female population 20-24
1313000 Persons
Population ages 20-24, female (% of female population)
8.86 %
Male population 20-24
1297000 Persons
Population ages 20-24, male (% of male population)
9.16 %
Female population 25-29
1062000 Persons
Population ages 25-29, female (% of female population)
7.21 %
Male population 25-29
1047000 Persons
Population ages 25-29, male (% of male population)
7.43 %
Female population 30-34
886000 Persons
Population ages 30-34, female (% of female population)
6.06 %
Male population 30-34
861000 Persons
Population ages 30-34, male (% of male population)
6.12 %
Female population 35-39
717000 Persons
Population ages 35-39, female (% of female population)
4.87 %
Male population 35-39
669000 Persons
Population ages 35-39, male (% of male population)
4.69 %
Female population 40-44
575000 Persons
Population ages 40-44, female (% of female population)
3.92 %
Male population 40-44
482000 Persons
Population ages 40-44, male (% of male population)
3.36 %
Female population 45-49
491000 Persons
Population ages 45-49, female (% of female population)
3.37 %
Male population 45-49
367000 Persons
Population ages 45-49, male (% of male population)
2.62 %
Female population 50-54
416000 Persons
Population ages 50-54, female (% of female population)
2.83 %
Male population 50-54
318000 Persons
Population ages 50-54, male (% of male population)
2.3 %
Female population 55-59
343000 Persons
Population ages 55-59, female (% of female population)
2.34 %
Male population 55-59
275000 Persons
Population ages 55-59, male (% of male population)
1.98 %
Female population 60-64
279000 Persons
Population ages 50-64, female (% of female population)
1.91 %
Male population 60-64
227000 Persons
Population ages 50-64, male (% of male population)
1.63 %
Female population 65-69
219000 Persons
Population ages 65-69, female (% of female population)
1.5 %
Male population 65-69
171000 Persons
Population ages 65-69, male (% of male population)
1.22 %
Population ages 65 and above (% of total)
3.35 %
Female population 70-74
160000 Persons
Population ages 70-74, female (% of female population)
1.09 %
Male population 70-74
118000 Persons
Population ages 70-74, male (% of male population)
0.8406 %
Female population 75-79
101000 Persons
Population ages 75-79, female (% of female population)
0.6854 %
Male population 75-79
70000 Persons
Population ages 75-79, male (% of male population)
0.4949 %
Population ages 80 and above, female
78000 Persons
Population ages 80 and above, female (% of female population)
0.5086 %
Male population 80+
49000 Persons
Population ages 80 and above, male (% of male population)
0.3333 %
Age population, age 06, female, interpolated
429544 Persons
Age population, age 06, male, interpolated
433348 Persons
Age population, age 07, female, interpolated
418493 Persons
Age population, age 07, male, interpolated
421697 Persons
Age population, age 08, female, interpolated
407671 Persons
Age population, age 08, male, interpolated
410332 Persons
Age population, age 09, female, interpolated
397004 Persons
Age population, age 09, male, interpolated
399174 Persons
Age population, age 10, female, interpolated
386539 Persons
Age population, age 10, male
388264 Persons
Age population, age 11, female, interpolated
376325 Persons
Age population, age 11, male
377647 Persons
Age population, age 12, female, interpolated
365688 Persons
Age population, age 12, male
366618 Persons
Age population, age 13, female, interpolated
354319 Persons
Age population, age 13, male
354844 Persons
Age population, age 14, female, interpolated
342503 Persons
Age population, age 14, male
342622 Persons
Age population, age 15, female, interpolated
330877 Persons
Age population, age 15, male, interpolated
330626 Persons
Age population, age 16, female, interpolated
319355 Persons
Age population, age 16, male, interpolated
318789 Persons
Age population, age 17, female, interpolated
307923 Persons
Age population, age 17, male, interpolated
306964 Persons
Age population, age 18, female, interpolated
296647 Persons
Age population, age 18, male, interpolated
295167 Persons
Age population, age 19, female, interpolated
285541 Persons
Age population, age 19, male, interpolated
283481 Persons
Age population, age 20, female, interpolated
274614 Persons
Age population, age 20, male, interpolated
271989 Persons
Age population, age 21, female, interpolated
263932 Persons
Age population, age 21, male, interpolated
260694 Persons
Age population, age 22, female, interpolated
253433 Persons
Age population, age 22, male, interpolated
249837 Persons
Age population, age 23, female, interpolated
243107 Persons
Age population, age 23, male, interpolated
239547 Persons
Age population, age 24, female, interpolated
233058 Persons
Age population, age 24, male, interpolated
229769 Persons
Age population, age 25, female, interpolated
223271 Persons
Age population, age 25, male, interpolated
220183 Persons
Age dependency ratio (% of working-age population)
94.75 %
Age dependency ratio, old (% of working-age population)
6.52 %
Age dependency ratio, young (% of working-age population)
88.23 %
Population, female (% of total)
51.15 %
Completeness of birth registration, rural
46.8 %
Completeness of birth registration, urban
50.6 %
Completeness of birth registration
47.9 %
Unmet need for family planning (for limiting) (% of married women): Q1 (lowest)
12.5 %
Unmet need for family planning (for limiting) (% of married women): Q2
10.9 %
Unmet need for family planning (for limiting) (% of married women): Q3
12.4 %
Unmet need for family planning (for limiting) (% of married women): Q4
12.9 %
Unmet need for family planning (for limiting) (% of married women): Q5 (highest)
16.2 %
Unmet need for family planning (for spacing) (% of married women): Q1 (lowest)
15.1 %
Unmet need for family planning (for spacing) (% of married women): Q2
16.9 %
Unmet need for family planning (for spacing) (% of married women): Q3
15.1 %
Unmet need for family planning (for spacing) (% of married women): Q4
15.5 %
Unmet need for family planning (for spacing) (% of married women): Q5 (highest)
15.4 %
Unmet need for contraception (% of married women ages 15-49)
23.9 %
Unmet need for family planning (total) (% of married women): Q1 (lowest)
27.7 %
Unmet need for family planning (total) (% of married women): Q2
27.8 %
Unmet need for family planning (total) (% of married women): Q3
27.5 %
Unmet need for family planning (total) (% of married women): Q4
28.4 %
Unmet need for family planning (total) (% of married women): Q5 (highest)
31.5 %